Rare diseases
Investigational molecules
Locations
Back to Spain546 clinical trials in Zaragoza, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Upadacitinib for Children with Moderate to Severe Crohn's Disease
SpainStudy of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment
SpainStudy on Niraparib for Patients with HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Detected by ctDNA
SpainStudy on Erdafitinib and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for Cisplatin Treatment
SpainStudy of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment
SpainStudy on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease
SpainStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
SpainStudy on Budesonide Tablets for Treating Eosinophilic Esophagitis in Adults
SpainStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
SpainStudy of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors
SpainStudy on Enzalutamide and Talazoparib for Treating Metastatic Hormone-Naïve Prostate Cancer in Patients
SpainStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on advanced cancer treatments and blood disorders, including studies of new therapies for lung cancer, pancreatic adenocarcinoma, and various hematologic malignancies.
Multiple trials evaluating combination therapies and novel treatment approaches for both solid tumors and blood cancers.
Research into treatments for various inflammatory and autoimmune disorders, with emphasis on chronic conditions affecting quality of life.
Studies focusing on innovative biological therapies and targeted treatments for inflammatory conditions.
Studies addressing critical cardiovascular health challenges and metabolic conditions, including innovative approaches to stroke treatment and lipid management.
Focus on developing new therapeutic options for both acute and chronic cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
